Volgen
Jinyu Li
Jinyu Li
Stony Brook University School of Medicine
Geverifieerd e-mailadres voor stonybrook.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Identification of driver genes in hepatocellular carcinoma by exome sequencing
SP Cleary, WR Jeck, X Zhao, K Chen, SR Selitsky, GL Savich, TX Tan, ...
Hepatology 58 (5), 1693-1702, 2013
3412013
Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma
K Revill, T Wang, A Lachenmayer, K Kojima, A Harrington, J Li, Y Hoshida, ...
Gastroenterology 145 (6), 1424-1435. e25, 2013
2572013
Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation
AJ Bott, IC Peng, Y Fan, B Faubert, L Zhao, J Li, S Neidler, Y Sun, N Jaber, ...
Cell metabolism 22 (6), 1068-1077, 2015
2322015
Therapeutic ablation of gain-of-function mutant p53 in colorectal cancer inhibits Stat3-mediated tumor growth and invasion
R Schulz-Heddergott, N Stark, SJ Edmunds, J Li, LC Conradi, ...
Cancer Cell 34 (2), 298-314. e7, 2018
1882018
Elasticity of short DNA molecules: theory and experiment for contour lengths of 0.6–7 μm
Y Seol, J Li, PC Nelson, TT Perkins, MD Betterton
Biophysical journal 93 (12), 4360-4373, 2007
1582007
KRAS drives immune evasion in a genetic model of pancreatic cancer
I Ischenko, S D’Amico, M Rao, J Li, MJ Hayman, S Powers, O Petrenko, ...
Nature communications 12 (1), 1482, 2021
1202021
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4
JM Catanzaro, N Sheshadri, JA Pan, Y Sun, C Shi, J Li, RS Powers, ...
Nature communications 5 (1), 3729, 2014
1032014
Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B
C Cai, M Rajaram, X Zhou, Q Liu, J Marchica, J Li, RS Powers
Cell Cycle 11 (9), 39-47, 2012
862012
System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity
M Rajaram, J Li, M Egeblad, RS Powers
PLoS genetics 9 (9), e1003789, 2013
822013
Development of patient-derived gastric cancer organoids from endoscopic biopsies and surgical tissues
M Gao, M Lin, M Rao, H Thompson, K Hirai, M Choi, GV Georgakis, ...
Annals of surgical oncology 25, 2767-2775, 2018
692018
Two distinct categories of focal deletions in cancer genomes
M Rajaram, J Zhang, T Wang, J Li, C Kuscu, H Qi, M Kato, V Grubor, ...
PLoS One 8 (6), e66264, 2013
582013
Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer
RD Merkin, EA Vanner, JL Romeiser, ALW Shroyer, LF Escobar-Hoyos, ...
Human Pathology 62, 23-32, 2017
482017
p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression
M Ghosh, S Saha, J Li, DC Montrose, LA Martinez
Molecular cell 83 (2), 266-280. e6, 2023
412023
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)
N Liu-Sullivan, J Zhang, A Bakleh, J Marchica, J Li, D Siolas, S Laquerre, ...
Oncotarget 2 (12), 1254, 2011
222011
Combinatorial CRISPR/Cas9 screening reveals epistatic networks of interacting tumor suppressor genes and therapeutic targets in human breast cancer
X Zhao, J Li, Z Liu, S Powers
Cancer Research 81 (24), 6090-6105, 2021
162021
Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma
J Li, M Chanrion, E Sawey, T Wang, E Chow, A Tward, Y Su, W Xue, ...
PLoS One 10 (3), e0118480, 2015
142015
Entropic elasticity of DNA with a permanent kink
J Li, PC Nelson, MD Betterton
Macromolecules 39 (25), 8816-8821, 2006
142006
Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis–specific targets in a patient with small intestinal neuroendocrine cancer
M Rao, K Oh, R Moffitt, P Thompson, J Li, J Liu, A Sasson, G Georgakis, ...
Molecular Case Studies 6 (2), a004978, 2020
132020
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
T Isermann, ÖÇ Şener, A Stender, L Klemke, N Winkler, A Neesse, J Li, ...
Nature Communications 12 (1), 4019, 2021
122021
Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas
J Li, R Sordella, S Powers
Scientific reports 6 (1), 27891, 2016
82016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20